APA citiranje

Geiger, M. J., Skrivanek, Z., Gaydos, B., Chien, J., Berry, S., Berry, D., & Anderson, J. H. (2012). An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics. Diabetes Technology Society.

Citação norma Chicago

Geiger, Mary Jane, Zachary Skrivanek, Brenda Gaydos, Jenny Chien, Scott Berry, Donald Berry, and James H. Anderson. An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics. Diabetes Technology Society, 2012.

MLA citiranje

Geiger, Mary Jane, et al. An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics. Diabetes Technology Society, 2012.